Prognostic Evaluation of Initial Bone Marrow Histopathological Features in Chronic Granulocytic Leukemia | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Prognostic Evaluation of Initial Bone Marrow Histopathological Features in Chronic Granulocytic Leukemia

Acta Haematol (1989) 82 (1): 12–15.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre‐staining processing of bone marrow biopsies

G Buesche
A Georgii
H‐H Kreipe

Histopathology (2006) 48 (2): 133.

Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia

G Buesche
M Freund
R Hehlmann
A Georgii
A Ganser
H Hecker
H Heimpel
C Fonatsch
B Heinze
M Pfirrmann
S Holgado
A Schmeil
A Tobler
J Hasford
T Buhr
H-H Kreipe

Leukemia (2004) 18 (9): 1460.

Evaluating the volume ratio of bone marrow affected by fibrosis: A parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia

Guntram Buesche
Axel Georgii
Anette Duensing
Anita Schmeil
Jerome Schlue
Hans-Heinrich Kreipe

Human Pathology (2003) 34 (4): 391.

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia – prospective long-term results from a randomized-controlled trial

G Buesche
R Hehlmann
H Hecker
H Heimpel
B Heinze
A Schmeil
M Pfirrmann
G Gomez
A Tobler
H Herrmann
M Kappler
J Hasford
T Buhr
H-H Kreipe
A Georgii

Leukemia (2003) 17 (12): 2444.

Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia – a multicentre study on 495 patients

Hans Michael Kvasnicka
Juergen Thiele
Annette Schmitt‐Graeff
Volker Diehl
Rudolf Zankovich
Norbert Niederle
Lutz‐Dietrich Leder
Hans Eckart Schaefer

British Journal of Haematology (2001) 112 (3): 727.

Bone Marrow Features Improve Prognostic Efficiency in Multivariate Risk Classification of Chronic-Phase Ph1+ Chronic Myelogenous Leukemia: A Multicenter Trial

Hans Michael Kvasnicka
Juergen Thiele
Annette Schmitt-Graeff
Volker Diehl
Rudolf Zankovich
Norbert Niederle
Lutz-Dietrich Leder
Hans Eckart Schaefer

Journal of Clinical Oncology (2001) 19 (12): 2994.

Bone Marrow Features and Clinical Findings in Chronic Myeloid Leukemia - A Comparative, Multicenter, Immunohistological and Morphometric Study on 614 Patients

Juergen Thiele
Hans Michael Kvasnicka
Annette Schmitt-Graeff
Thomas Karl Zirbes
Florian Birnbaum
Christian Kressmann
Manuel Melguizo-Grahmann
Holger Frackenpohl
Claudia Sprungmann
Lutz-Dietrich Leder
Volker Diehl
Rudolf Zankovich
Hans Eckart Schaefer
Norbert Niederle
Robert Fischer

Leukemia & Lymphoma (2000) 36 (3-4): 295.

Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia

J Thiele
H M Kvasnicka
A Schmitt‐Graeff
L D Leder
H E Schaefer

Histopathology (2000) 37 (4): 355.

2 The histopathology of chronic myeloproliferative diseases

A. Georgii
G. Buesche
A. Kreft

Baillière's Clinical Haematology (1998) 11 (4): 721.

Clinical and histological features retain their prognostic impact under interferon therapy of CML: A pilot study

Juergen Thiele
Hans Michael Kvasnicka
Norbert Niederle
Otto Kloke
Marcus Schmidt
Heiko Lienhard
Thomas Zirbes
Raoul Boris Meuter
Lutz Dietrich Leder
Robert Fischer

American Journal of Hematology (1995) 50 (1): 30.

Prognosis of Chronic Myeloid Leukemia: Studies from the Barcelona Group

Ciril Rozman
Francisco Cervantes
María Rozman
Alvaro Urbano-Ispizua

Leukemia & Lymphoma (1993) 11 (sup1): 63.

Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia

Akimichi Ohsaka
Yasusada Miura
Atsushi Takahashi
Takeshi Yokoyama

Virchows Archiv B Cell Pathology Including Molecular Pathology (1991) 60 (1): 399.